Hypothesis: Myostatin is a mediator of cardiac cachexia

International Journal of Cardiology

Volumn 124, Issue 2, 2008, Pages 131-133

  Hoenig, Michel R ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Cachexia; Heart failure; Myostatin; Neurohumoral

Indexed keywords

HYDROCORTISONE; MYOSTATIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CACHEXIA; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; EDITORIAL; EXERCISE; HEART FAILURE; HUMAN; INSULIN RESISTANCE; MORTALITY; MUSCLE ATROPHY; MUTATION; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL MARKERS; BODY MASS INDEX; CACHEXIA; CROSS-SECTIONAL STUDIES; DISEASE MODELS, ANIMAL; HEART FAILURE; HUMANS; INSULIN RESISTANCE; MICE; OSTEOPOROSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA;

EID: 38749120993     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.058     Document Type: Editorial

References (19)

1. Anker S.D., and Coats A.J.S. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115 3 (1999) 836-847
2. Greenlund L.J., and Nair K.S. Sarcopenia-consequences, mechanisms, and potential therapies. Mech Ageing Dev 124 3 (2003) 287-299
3. Toth M.J., Gottlieb S.S., Fisher M.L., and Poehlman E.T. Skeletal muscle atrophy and peak oxygen consumption in heart failure. Am J Cardiol 79 9 (1997) 1267-1269
4. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 2 (1997) 526-534
5. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 4 (1990) 236-241
6. McMurray J., Abdullah I., Dargie H.J., and Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 66 5 (1991) 356-358
7. Anker S.D., Ponikowski P.P., Clark A.L., et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 20 9 (1999) 683-693
8. McPherron A.C., Lawler A.M., and Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387 6628 (1997) 83-90
9. McPherron A.C., and Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. PNAS 94 23 (1997) 12457-12461
10. Schuelke M., Wagner K.R., Stolz L.E., et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350 26 (2004) 2682-2688
11. Zimmers T.A., Davies M.V., Koniaris L.G., et al. Induction of cachexia in mice by systemically administered myostatin. Science 296 5572 (2002) 1486-1488
12. Ma K., Mallidis C., Artaza J., Taylor W., Gonzalez-Cadavid N., and Bhasin S. Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 281 6 (2001) E1128-E1136
13. Artaza J.N., Bhasin S., Mallidis C., Taylor W., Ma K., and Gonzalez-Cadavid N.F. Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol 190 2 (2002) 170-179
14. Lang C.H., Silvis C., Nystrom G., and Frost R.A. Regulation of myostatin by glucocorticoids after thermal injury. FASEB J 15 10 (2001) 1807-1809
15. Yarasheski K.E., Bhasin S., Sinha-Hikim I., Pak-Loduca J., and Gonzalez-Cadavid N.F. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 6 5 (2002) 343-348
16. Gonzalez-Cadavid N.F., Taylor W.E., Yarasheski K., et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. PNAS 95 25 (1998) 14938-14943
17. Sharma M., Kambadur R., Matthews K.G., et al. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180 1 (1999) 1-9
18. Shyu K.G., Lu M.J., Wang B.W., Sun H.Y., and Chang H. Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. Eur J Clin Invest 36 10 (2006) 713-719
19. Herndon D.N., Hart D.W., Wolf S.E., Chinkes D.L., and Wolfe R.R. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 345 17 (2001) 1223-1229